Fig. 2From: Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary interventionKaplan–Meier survival curves according to the median of GA. A Kaplan–Meier survival curves for the primary endpoint in the entire population; B Kaplan–Meier survival curves for the primary endpoint in the patients with T2DM; C Kaplan–Meier survival curves for the primary endpoint in the patients without T2DM. GA glycated albumin, MACCE major adverse cardio-cerebral eventsBack to article page